Sung‐Han Kim
- Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research 66
- Antimicrobial Resistance in Staphylococcus 63
- Tuberculosis Research and Epidemiology 58
- COVID-19 Clinical Research Studies 47
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 47
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 63
- Epidemiology top 0.2%
- Pneumocystis jirovecii pneumonia detection and treatment 44
-
- Infectious Diseases and Tuberculosis 57
- Co-authors
- Sang‐Ho ChoiJun Hee WooYang Soo KimHong Bin KimSang‐Oh LeeKang Won ChoeMyoung‐don OhCheol‐In Kang
- Journals
- Journal of Korean Medical Science (27 papers)Open Forum Infectious Diseases (20 papers)European Journal of Clinical Microbiology & Infectious Diseases (19 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Sung‐Han Kim
585 papers receiving 14.0k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Applied Microbiology and Biotechnology 891
- Infectious Diseases 5.9k
- Molecular Medicine 1.5k
- Clinical Biochemistry 1.6k
- Epidemiology 5.0k
Countries citing papers authored by Sung‐Han Kim
This map shows the geographic impact of Sung‐Han Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Han Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Han Kim more than expected).
Fields of papers citing papers by Sung‐Han Kim
This network shows the impact of papers produced by Sung‐Han Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Han Kim. The network helps show where Sung‐Han Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sung‐Han Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitorbreakdown → | 2024 | 81 |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 16 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 44 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 3 | |
| 17 | 2019 | 3 | |
| 18 | 2017 | 32 | |
| 19 | 2009 | 13 | |
| 20 | A Multichannel Audio Codec System for Multichannel Audio Authoring | 1999 | 1 |
About Sung‐Han Kim
Sung‐Han Kim is a scholar working on Infectious Diseases, Molecular Medicine, Clinical Biochemistry, Applied Microbiology and Biotechnology and Epidemiology, having authored 625 papers that have together received 14.4k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (66 papers), Antimicrobial Resistance in Staphylococcus (63 papers), Bacterial Identification and Susceptibility Testing (63 papers), Tuberculosis Research and Epidemiology (58 papers), Infectious Diseases and Tuberculosis (57 papers), Antibiotic Resistance in Bacteria (47 papers), COVID-19 Clinical Research Studies (47 papers) and Pneumocystis jirovecii pneumonia detection and treatment (44 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (891 citations), Infectious Diseases (5.9k citations), Molecular Medicine (1.5k citations), Clinical Biochemistry (1.6k citations) and Epidemiology (5.0k citations). Sung‐Han Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Sang‐Ho Choi, Jun Hee Woo, Yang Soo Kim, Hong Bin Kim, Sang‐Oh Lee, Kang Won Choe, Myoung‐don Oh, Cheol‐In Kang, Wan Beom Park and Jiwon Jung. Their work appears in journals such as Journal of Korean Medical Science, Open Forum Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Clinical Infectious Diseases and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.